CorMedix Inc.

NasdaqGM:CRMD 株式レポート

時価総額:US$688.7m

CorMedix マネジメント

マネジメント 基準チェック /34

CorMedixの CEO はJoe Todiscoで、 May2022年に任命され、 の在任期間は 2.5年です。 の年間総報酬は$ 2.46Mで、 25.1%給与と74.9%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.3%を直接所有しており、その価値は$ 2.09M 。経営陣と取締役会の平均在任期間はそれぞれ2.5年と2.7年です。

主要情報

Joe Todisco

最高経営責任者

US$2.5m

報酬総額

CEO給与比率25.1%
CEO在任期間2.5yrs
CEOの所有権0.3%
経営陣の平均在職期間2.5yrs
取締役会の平均在任期間2.7yrs

経営陣の近況

Here's Why CorMedix Inc.'s (NASDAQ:CRMD) CEO Compensation Is The Least Of Shareholders' Concerns

Nov 14
Here's Why CorMedix Inc.'s (NASDAQ:CRMD) CEO Compensation Is The Least Of Shareholders' Concerns

Recent updates

Here's Why CorMedix Inc.'s (NASDAQ:CRMD) CEO Compensation Is The Least Of Shareholders' Concerns

Nov 14
Here's Why CorMedix Inc.'s (NASDAQ:CRMD) CEO Compensation Is The Least Of Shareholders' Concerns

Analysts Just Made A Massive Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Forecasts

Nov 04
Analysts Just Made A Massive Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Forecasts

CorMedix 2.0: New Leadership, New Approval, New Focus

Oct 28

CorMedix: Delayed Approval, Low Cash, Good Prospects

Oct 19

We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely

Sep 30
We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely

We Think CorMedix (NASDAQ:CRMD) Can Afford To Drive Business Growth

Apr 06
We Think CorMedix (NASDAQ:CRMD) Can Afford To Drive Business Growth

We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely

Nov 02
We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation

Jul 31
Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation

CorMedix (NASDAQ:CRMD) Is In A Good Position To Deliver On Growth Plans

Feb 25
CorMedix (NASDAQ:CRMD) Is In A Good Position To Deliver On Growth Plans

FDA again rejects CorMedix's application for lead candidate DefenCath, shares sink ~60%

Aug 08

Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation

Jul 16
Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation

We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely

Mar 01
We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation

Sep 09
Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation

CorMedix Inc.'s (NASDAQ:CRMD) Intrinsic Value Is Potentially 58% Above Its Share Price

Feb 11
CorMedix Inc.'s (NASDAQ:CRMD) Intrinsic Value Is Potentially 58% Above Its Share Price

We're Hopeful That CorMedix (NYSEMKT:CRMD) Will Use Its Cash Wisely

Jan 04
We're Hopeful That CorMedix (NYSEMKT:CRMD) Will Use Its Cash Wisely

CEO報酬分析

CorMedix の収益と比較して、Joe Todisco の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$46m

Jun 30 2024n/an/a

-US$53m

Mar 31 2024n/an/a

-US$50m

Dec 31 2023US$2mUS$617k

-US$46m

Sep 30 2023n/an/a

-US$40m

Jun 30 2023n/an/a

-US$37m

Mar 31 2023n/an/a

-US$33m

Dec 31 2022US$3mUS$378k

-US$30m

報酬と市場: Joeの 総報酬 ($USD 2.46M ) は、 US市場 ($USD 3.21M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Joeの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Joe Todisco (48 yo)

2.5yrs

在職期間

US$2,459,432

報酬

Mr. Joseph Todisco, also known as Joe, MBA, serves as Chief Executive Officer of CorMedix Inc. since May 10, 2022. He has served as Director of CorMedix Inc. since March 18, 2022 and served as its Independ...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Joseph Todisco
CEO & Director2.5yrsUS$2.46m0.30%
$ 2.1m
Matthew David
Executive VP & CFO4.5yrsUS$1.03m0.017%
$ 118.5k
Erin Mistry
Executive VP & Chief Commercial Officer4.7yrsUS$1.26m0.021%
$ 147.7k
Elizabeth Masson-Hurlburt
Executive VP and Chief Clinical Strategy & Operations Officerless than a yearUS$844.81k0.013%
$ 89.6k
Kaufman Zelnick
Executive VPless than a yearデータなしデータなし
Donna Ucci
Senior VP & Head of Global Quality2.5yrsデータなしデータなし
Tushar Mukherjee
Senior VP & Head of Technical Operations1.8yrsデータなしデータなし

2.5yrs

平均在職期間

47yo

平均年齢

経験豊富な経営陣: CRMDの経営陣は 経験豊富 であると考えられます ( 2.5年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Joseph Todisco
CEO & Director2.7yrsUS$2.46m0.30%
$ 2.1m
Myron Kaplan
Independent Chairman of the Board8.6yrsUS$191.96k0.30%
$ 2.1m
Alan Dunton
Independent Director5.7yrsUS$141.42k0.025%
$ 173.1k
Janet Dillione
Independent Director9.3yrsUS$147.42k0.088%
$ 606.9k
Steven Lefkowitz
Independent Director7.4yrsUS$162.42k0.13%
$ 879.6k
Gregory Duncan
Independent Director4yrsUS$141.42k0%
$ 0
Bruce Polsky
Member of Scientific Advisor Boardno dataデータなしデータなし
Saravanan Balamuthusamy
Member of Scientific Advisory Board2.6yrsデータなしデータなし
Sara Bonnes
Member of Scientific Advisory Board2.6yrsデータなしデータなし
Aru Narendran
Member of Scientific Advisory Board2.6yrsデータなしデータなし
Hannah Newman
Member of Scientific Advisory Board2.6yrsデータなしデータなし
Jonathan Waitman
Member of Scientific Advisory Board2.6yrsデータなしデータなし

2.7yrs

平均在職期間

68yo

平均年齢

経験豊富なボード: CRMDの 取締役会経験豊富 ではない ( 2.7年の平均在任期間) ため、新しい取締役会が必要であると考えられます。